Endo International Ordinary Shares reported $142.99M in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Aerie Pharmaceuticals AERI:US $ 7.36M 0.24M
Amarin AMRN:US $ 0.39M 0.36M
Ani Pharmaceuticals ANIP:US $ 2.5M 34K
Bristol Myers Squibb BMY:US $ 328M 2M
Coherus Biosciences CHRS:US $ 5.77M 0.02M
Eli Lilly And LLY:US $ 83.6M 3.3M
Endo International Ordinary Shares ENDP:US $ 142.99M 1.35M
Flexion Therapeutics FLXN:US $ 6.29M 1.11M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Lannett LCI:US $ 14.22M 1.01M
Ligand Pharmaceuticals LGND:US $ 4.44M 0.44M
Novartis NOVN:VX 202M 1000K
Pacira Pharmaceuticals PCRX:US $ 7.33M 0.31M
Patterson Companies PDCO:US $ 5.52M 0.33M
Pfizer PFE:US $ 325M 9M
Phibro Animal Health PAHC:US $ 3.06M 0.03M
Revance Therapeutics RVNC:US $ 1.57M 2K
Supernus Pharmaceuticals SUPN:US $ 5.92M 1.43M
Teva Pharmaceutical TEVA:IT 232M 8M
Xeris Pharmaceuticals Inc XERS:US $ 1.8M 3K
Zoetis ZTS:US $ 56M 1M